Clinical trial

Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer

NCT00096356 · Wake Forest University Health Sciences, Other · Completed

Key facts

NCT number NCT00096356
Title Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
Official title A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Acronym CoQ10
Lead sponsor Wake Forest University Health Sciences, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Breast Cancer, Fatigue
Intervention type Dietary Supplement
Interventions CoQ10 & Vitamin E, Placebo & Vitamin E
Enrollment 236
Start date Aug 27, 2004
Primary completion Aug 31, 2009
Completion Aug 31, 2009
First posted Nov 9, 2004
Last update posted Sep 29, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies